Sorry, You Probably Cannot Get MDMA Through Telehealth
Lykos’ current application is based on MDMA-assisted therapy, and FDA will almost surely require that patients take the drug in a clinical setting.
REMS
-
Read more: Sorry, You Probably Cannot Get MDMA Through Telehealth -
Read more: Gender-Affirming Care, Abortion, and the Politics of Science: A Response to Wuest’s ‘Born this Way’ Gender-Affirming Care, Abortion, and the Politics of Science: A Response to Wuest’s ‘Born this Way’
Wuest highlights the contingency of scientific claims not only in LGBTQ+ advocacy but also in legal advocacy for and against abortion access.
-
Read more: The Leaked Dobbs Opinion, Explained The Leaked Dobbs Opinion, Explained
The background of the case, the contents of the draft opinion, and potential implications for abortion access and other rights.
-
Read more: How Social Movements Have Facilitated Access to Abortion During the Pandemic How Social Movements Have Facilitated Access to Abortion During the Pandemic
Further on-the-ground innovations, outside the courtroom and across state borders, will be needed to meet future challenges to abortion access.
-
Read more: COVID-19 and the New Reproductive Justice Movement COVID-19 and the New Reproductive Justice Movement
The pandemic finally shifted the reproductive justice movement’s focus to abortion access, rather than abortion rights.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from the month of April 2021.
-
Read more: FDA Expands Medication Abortion Access During Pandemic, but State Barriers Remain FDA Expands Medication Abortion Access During Pandemic, but State Barriers Remain
Advocates for abortion access are celebrating the FDA decision as a win for science and evidence-based policy.
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from October 2020.
